Jaguar Health Inc. (NASDAQ: JAGX) open the trading on September 28, 2020, with a bit cautious approach as it glided -1.83% to $0.31. During the day, the stock rose to $0.319 and sunk to $0.3023 before settling in for the price of $0.31 at the close. Taking a more long-term approach, JAGX posted a 52-week range of $0.29-$1.38.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -311.40%. This publicly-traded company’s shares outstanding now amounts to $23.89 million, simultaneously with a float of $0.74 million. The organization now has a market capitalization sitting at $12.36 million. At the time of writing, stock’s 50-day Moving Average stood at $0.5098, while the 200-day Moving Average is $0.5629.
It is quite necessary to find out the efficiency of the corporate organization, which has 29 number of employees on its payroll. It has generated 199,147 per worker during the last fiscal year. Meanwhile, its income per employee was -1,328,946. The stock had 4.28 Receivables turnover and 0.15 Total Asset turnover. For the Profitability, stocks gross margin was +33.93, operating margin was -420.75 and Pretax Margin of -667.15.
Jaguar Health Inc. (JAGX) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Jaguar Health Inc.’s current insider ownership accounts for 10.37%, in contrast to 3.10% institutional ownership.
Jaguar Health Inc. (JAGX) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 6/29/2020 suggests? It has posted -$0.29 earnings per share (EPS) not meeting the forecaster’s viewpoint (set at -$0.15) by -$0.14. This company achieved a net margin of -667.32 while generating a return on equity of -220.53. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
Jaguar Health Inc.’s EPS decrease for this current 12-month fiscal period is -311.40% and is forecasted to reach -0.46 in the upcoming year.
Jaguar Health Inc. (NASDAQ: JAGX) Trading Performance Indicators
Let’s observe the current performance indicators for Jaguar Health Inc. (JAGX). It’s Quick Ratio in the last reported quarter now stands at 0.40. The Stock has managed to achieve an average true range (ATR) of 0.04. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.90.
In the same vein, JAGX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.69, a figure that is expected to reach -0.14 in the next quarter, and analysts are predicting that it will be -0.46 at the market close of one year from today.
Technical Analysis of Jaguar Health Inc. (JAGX)
[Jaguar Health Inc., JAGX] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 17.29% While, its Average True Range was 0.0371.
Raw Stochastic average of Jaguar Health Inc. (JAGX) in the period of the previous 100 days is set at 3.69%, which indicates a major fall in contrast to 7.91% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 75.04% that was lower than 122.73% volatility it exhibited in the past 100-days period.